Eli Lilly and Company (NYSE:LLY) Shares Acquired by Marcum …

1 day ago · Marcum Wealth LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 6.6% in the fourth quarter, according to its most recent filing with the …

6%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By Marcum …

2 weeks from now

1 day ago · Marcum Wealth LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 6.6% in the fourth quarter, according to its most recent filing with the …

modernreaders.com

2%
OFF

Unique Wealth LLC Acquires 1,053 Shares Of Eli Lilly And Company …

2 weeks from now

2 days ago · Unique Wealth LLC raised its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 75.2% in the 4th quarter, according to the company in its most …

marketbeat.com

$1.18
OFF

Board Of The Pension Protection Fund Acquires Shares Of 600 Eli …

2 weeks from now

13 hours ago · Eli Lilly and Company (NYSE:LLY - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.18 earnings per share …

marketbeat.com

5%
OFF

Marcum Wealth LLC Buys 247 Shares Of Eli Lilly And Company …

2 weeks from now

Oct 11, 2024 · Marcum Wealth LLC boosted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 8.5% in the third quarter, according to its most recent Form 13F …

defenseworld.net

$1.18
OFF

Rep. Josh Gottheimer Sells Eli Lilly And Company (NYSE:LLY) Shares

2 weeks from now

13 hours ago · Eli Lilly and Company (NYSE:LLY - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.18 earnings per …

marketbeat.com

5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

2 weeks from now

1 day ago · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

yahoo.com

$15
OFF

Lilly Announces New $15 Billion Share Repurchase Program And …

2 weeks from now

INDIANAPOLIS, Dec. 9, 2024 /PRNewswire/ -- Today, the board of directors of Eli Lilly and Company (NYSE: LLY) approved a new $15 billion share repurchase program. The company's …

lilly.com

4%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Purchased By

2 weeks from now

Jan 8, 2025 · Legacy Private Trust Co. increased its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 10.4% during the fourth quarter, according to its most recent 13F filing with …

marketbeat.com

$1.18
OFF

Eli Lilly And Company (NYSE:LLY) Shares Bought By Clarus

2 weeks from now

13 hours ago · Eli Lilly and Company (NYSE:LLY - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.18 earnings per share …

marketbeat.com

4%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By ... - MarketBeat

2 weeks from now

13 hours ago · Community Trust & Investment Co. lifted its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 37.4% in the 4th quarter, according to the company in its most …

marketbeat.com

9%
OFF

Range Financial Group LLC Acquires 3,744 Shares Of Eli Lilly And ...

2 weeks from now

Jan 7, 2025 · Range Financial Group LLC increased its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 476.9% during the fourth quarter, according to its …

marketbeat.com

$1.18
OFF

Eli Lilly And Company (NYSE:LLY) Stock Holdings Lessened

2 weeks from now

13 hours ago · Eli Lilly and Company (NYSE:LLY - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.18 earnings per share for the …

marketbeat.com

3%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Acquired By Czech

2 weeks from now

3 days ago · Czech National Bank boosted its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 6.3% in the fourth quarter, according to its most recent disclosure with the …

marketbeat.com

2%
OFF

Eli Lilly And Company (NYSE:LLY) Shares Sold By Salem Investment ...

2 weeks from now

3 days ago · Salem Investment Counselors Inc. decreased its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 3.2% during the 4th quarter, according to the …

marketbeat.com

FAQs about Eli Lilly and Company (NYSE:LLY) Shares Acquired by Marcum … Coupon?

Why are Eli Lilly shares down 76% today?

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 billion in revenue for Q4 2024, compared to the consensus estimate of $13.97 billion. ...

Is Eli Lilly acquiring morphic?

INDIANAPOLIS and WALTHAM, Mass., July 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases. ...

Did Eli Lilly acquire point Biopharma global (PNT)?

INDIANAPOLIS, Dec. 27, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of POINT Biopharma Global Inc. (NASDAQ: PNT), a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer. ...

Will Lilly buy morphic?

Lilly will commence a tender offer to acquire all outstanding shares of Morphic for a purchase price of $57 per share in cash (an aggregate of approximately $3.2 billion) payable at closing. The transaction has been approved by the boards of directors of both companies. ...

How much will Eli Lilly make in 2025?

Eli Lilly also mentioned that they were short on channel inventory levels at year-end that also insist the company to lower the guidance for full year 2024. Nevertheless, Eli Lilly is highly confident about its further development, projecting revenue for 2025 in the range of $58.0 billion to $61.0 billion. ...

Is Eli Lilly competing with Novo Nordisk & Ozempic?

Both companies are competing in GLP-1 (Glucagon-like Peptide-1) receptor agonists that help in promoting weight loss. BioSpace reported that Eli Lilly faces fierce competition from Novo Nordisk (NYSE:NVO)'s Wegovy and Ozempic, which has led to lower-than-expected demand for Eli Lilly's weight loss and diabetes medications, Mounjaro and Zepbound. ...